Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Spain; Servicio de Cardiología, Complejo Asistencial Universitario de Salamanca, Salamanca, Spain.
Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Spain; Servicio de Cardiología, Complejo Asistencial Universitario de Salamanca, Salamanca, Spain.
Rev Esp Cardiol (Engl Ed). 2023 Apr;76(4):253-260. doi: 10.1016/j.rec.2022.05.019. Epub 2022 Jun 9.
Transfemoral access is the most frequently used vascular approach in chronic total occlusion percutaneous coronary interventions (CTO-PCI). The aim of this study was to evaluate the safety and feasibility of a transradial access CTO-PCI program and its impact on angiographic and clinical results and length of hospital stay.
Retrospective multicenter cohort study including 2550 consecutive CTO-PCI procedures included in a multicenter registry with accurate information on vascular access. A total of 896 procedures were performed as radial-only access while 1654 were performed through at least 1 femoral puncture. Clinical and angiographic data were collected.
The mean age was 66.3± 11.4 years. The mean Japan-chronic total occlusion score (2.7±0.3) was similar in the 2 groups. Successful revascularization was achieved in 2009 (79.6%) cases, 78.2% and 82.1% in the femoral and radial access cohorts, respectively (P=.002). Periprocedural in-hospital complications were observed in 5.1% and 2.3% (P=.02), with fewer access site-dependant vascular complications in the transradial cohort (2.3% vs 0.2%; P=.009). The mean length of hospital stay was significantly shorter in the transradial access group (0.89±1.4 vs 2.2±3.2 days, P<.001).
A transradial program for CTO-PCI is safe and effective in most CTO lesions. The transradial strategy has fewer vascular complications and shorter length of hospital stay without compromising the success rate.
经股动脉入路是慢性全闭塞经皮冠状动脉介入治疗(CTO-PCI)中最常使用的血管入路。本研究旨在评估经桡动脉入路 CTO-PCI 方案的安全性和可行性,及其对血管造影和临床结果以及住院时间的影响。
回顾性多中心队列研究,纳入了一个多中心注册研究中的 2550 例连续 CTO-PCI 手术,该研究有关于血管入路的准确信息。共 896 例手术仅采用桡动脉入路,1654 例手术至少有 1 次股动脉穿刺。收集临床和血管造影数据。
平均年龄为 66.3±11.4 岁。两组的平均日本慢性全闭塞评分(2.7±0.3)相似。2009 年成功再血管化率为 79.6%,股动脉和桡动脉入路组分别为 78.2%和 82.1%(P=.002)。围手术期院内并发症发生率为 5.1%和 2.3%(P=.02),桡动脉入路组的血管并发症发生率较低(2.3% vs 0.2%;P=.009)。桡动脉入路组的平均住院时间明显缩短(0.89±1.4 vs 2.2±3.2 天,P<.001)。
在大多数 CTO 病变中,经桡动脉 CTO-PCI 方案是安全有效的。桡动脉策略的血管并发症较少,住院时间较短,而不影响成功率。